Skip to main content

Nader Francois's Form 4/A amendment

Amended

Tourmaline Bio, Inc.TRML · filed Sep 13, 2022

Accession no.
0000899243-22-030924
Filed
Sep 13, 2022
Trade date
Jul 19-25, 2022
Filing delay
56 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Jul 25, 2022

This filing lists 7 non-derivative transactions. Open-market purchases total $500.0K. It was filed 56 days after the trade.

This amendment replaces 0000899243-22-026684 (filed Jul 25, 2022).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Nader FrancoisCIK 0001365343Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 19, 2022Common StockPPurchaseAcquired+50,000$3.52F1+$176,00050,000Direct
Jul 20, 2022Common StockPPurchaseAcquired+52,000$3.62F2+$188,240102,000Direct
Jul 21, 2022Common StockJOtherDisposed−248,432$0.00$0147,255Indirect
Jul 21, 2022Common StockJOtherAcquired+248,432$0.00$0248,432Indirect
Jul 21, 2022Common StockPPurchaseAcquired+36,500$3.72F6+$135,780138,500Direct
Jul 25, 2022Common StockJOtherDisposed−138,500$0.00$00Direct
Jul 25, 2022Common StockJOtherAcquired+138,500$0.00$0386,932Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.38 to $3.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F2

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.51 to $3.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F3

Represents the transfer of shares held by the Francois Nader 2020 Trust to FN TALS LLC for no consideration.

F4

These shares are held in a trust for the benefit of the Reporting Person's spouse and child. The Reporting Person''s spouse and child are trustees of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F5

These shares are held by a limited liability company of which the Reporting Person serves as the sole member, with sole voting and investment control over the securities held thereby. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F6

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.595 to $3.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F7

Represents the transfer of shares held by the Reporting Person to FN TALS LLC for no consideration.

F8

This amendment is being filed solely to correct the number of shares reported by the Francois Nader 2020 Trust, which was incorrectly reported due to an administrative error.

Read the full filing on SEC EDGAR (opens in a new tab)